The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
How to Help Your Patients Find Atomoxetine (Strattera) in Stock: A Provider's Guide
A practical guide for prescribers on helping ADHD patients find generic atomoxetine when pharmacies report it as out of stock in 2026.

Doptelet Shortage: What Providers and Prescribers Need to Know in 2026
Doptelet is not in shortage, but access challenges are real. This 2026 guide helps hematologists, hepatologists, and prescribers navigate the specialty pharmacy system for their patients.

Ethinyl Estradiol/Levonorgestrel Shortage: What Providers and Prescribers Need to Know in 2026
No national FDA shortage exists for ethinyl estradiol/levonorgestrel, but your patients are still struggling to fill prescriptions. Here's what providers need to know in 2026.

Mexiletine Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for cardiologists, electrophysiologists, and PCPs on mexiletine supply challenges, alternative antiarrhythmic strategies, and patient counseling in 2026.
48,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Natroba Shortage: What Providers and Prescribers Need to Know in 2026
Natroba is not in an FDA shortage, but pharmacy availability is inconsistent. Here's a clinical briefing for providers on access challenges, PA strategies, and patient guidance.

Permethrin Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for providers on permethrin availability in 2026, resistance patterns, and evidence-based alternatives for scabies and pediculosis.

Proferrin Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of Proferrin availability in 2026 for providers: supply status, therapeutic alternatives, patient counseling tips, and when IV iron is the right call.

Promethazine Shortage: What Providers and Prescribers Need to Know in 2026
The promethazine injection shortage is affecting hospital formularies in 2026. Here's a clinical guide for providers on alternatives, patient communication, and managing supply gaps.

Rabeprazole Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for prescribers on rabeprazole availability in 2026 — including supply status, therapeutic alternatives, patient counseling points, and formulary considerations.

Triamcinolone Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on the 2026 triamcinolone injectable shortage: supply status, prescribing alternatives, formulary implications, and patient communication strategies.

Urocit-K XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical update for urologists, nephrologists, and PCPs on Urocit-K XR availability in 2026: what's causing stocking gaps, evidence-based alternatives, and how to help patients stay on therapy.

Verapamil Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of verapamil supply disruptions for prescribers in 2026. Includes shortage history, formulation-level supply status, and therapeutic alternatives.